Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.99
AETHLON MEDICAL INC shareholders approved Approve, pursuant to Nevada Revised Statutes (“NRS”) 78.2055, a reverse stock split of our common stock at a ratio in the range of 1-for-8 to 1-for-12, with such ratio to be determined in the discretion of the Board and with such reverse stock split to be effected at such time and date as determined at the 2023-09-15 meeting.
- Proposal
- reverse split
- Outcome
- passed
- Meeting
- 2023-09-15
Exact text from the filing
Approve, pursuant to Nevada Revised Statutes (“NRS”) 78.2055, a reverse stock split of our common stock at a ratio in the range of 1-for-8 to 1-for-12, with such ratio to be determined in the discretion of the Board and with such reverse stock split to be effected at such time and date as determined by the Board in its sole discretion (but in no event later than October 5, 2023). The resolution was approved. Votes For Votes Against Abstentions 6,781,311 2,180,424 51,219
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.99
AETHLON MEDICAL INC shareholders approved Elect six members of our Board of Directors at the 2023-09-15 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2023-09-15
Exact text from the filing
Elect six members of our Board of Directors (the “Board”). All of the nominees were elected. Name Votes For Votes Against Abstentions Edward G. Broenniman 4,746,036 435,339 120,979 Guy F. Cipriani 4,859,449 322,920 119,985 Charles J. Fisher, Jr., MD 4,857,852 328,276 116,226 Nicolas Gikakis 4,859,443 321,710 121,201 Angela Rossetti 4,855,281 327,149 119,924 Chetan S. Shah, MD 4,870,838 316,233 115,283
View on SEC.gov